MARKET WIRE NEWS

Harrow, Inc. (HROW) Q2 2025 Earnings Call Transcript

Source: SeekingAlpha

2025-08-12 14:47:49 ET

Harrow, Inc. (HROW)

Q2 2025 Earnings Call

August 12, 2025 8:00 A.M. ET

Company Participants

Andrew R. Boll - CFO & Corporate Secretary

Mark L. Baum - CEO & Chairman of the Board

Michael D. Biega - Vice President of Investor Relations & Communications

Conference Call Participants

Chase Richard Knickerbocker - Craig-Hallum Capital Group LLC, Research Division

Jeffrey Scott Cohen - Ladenburg Thalmann & Co. Inc., Research Division

Lachlan Hanbury-Brown - William Blair & Company L.L.C., Research Division

Mayank Mamtani - B. Riley Securities, Inc., Research Division

Steven James Seedhouse - Cantor Fitzgerald & Co., Research Division

Thomas Flaten - Lake Street Capital Markets, LLC, Research Division

Thomas Eugene Shrader - BTIG, LLC, Research Division

Yi Chen - H.C. Wainwright & Co, LLC, Research Division

Presentation

Michael D. Biega

Thank you, operator. Good morning, and welcome to Harrow's second quarter 2025 earnings conference call. My name is Mike Biega, and I'm excited to be introducing today's call, having joined Harrow as Vice President of Investor Relations and Communications in June. It's a pleasure to be part of the Harrow family and to speak with all of you this morning.

Before we begin today, I would like to highlight a few new items for our quarterly report. We will be presenting slides during the webcast today. If you have registered and joined through the live conference call link, I would highly recommend that you also join through the webcast. You can find the link in the Investors Events section of our website at www.harrow.com or in our earnings press release that was issued yesterday. We also have a new corporate deck that was posted on our website yesterday. All of the slides we will be presenting today can be found in that deck. Moving forward, you should expect that our earnings process will mirror this format with potentially a few additional changes, and we will certainly update you on any future changes to this format. In addition, we recently launched a new corporate website, which I encourage all of you to explore....

Read the full article on Seeking Alpha

For further details see:

Harrow, Inc. (HROW) Q2 2025 Earnings Call Transcript
Harrow Health Inc. 8.625% senior notes due 2026

NASDAQ: HROWL

HROWL Trading

0.11% G/L:

$25.591 Last:

3,436 Volume:

$25.55 Open:

mwn-alerts Ad 300

HROWL Latest News

May 23, 2025 02:16:00 am
Long Term Trading Analysis for (HROWL)
February 28, 2025 12:14:00 am
Objective long/short (HROWL) Report
February 17, 2025 09:52:00 am
Where are the Opportunities in (HROWL)

HROWL Stock Data

$947,624,703
31,392,612
N/A
160
6427%
Pharmaceuticals
Healthcare
US
Nashville

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App